Table 1 Baseline characteristics at the time when treatment decision between Hemodialysis and peritoneal dialysis.
Indicators | Before PSM | After PSM | P-value | |||
|---|---|---|---|---|---|---|
PD(n = 101) | HD(n = 133) | P-value | PD(n = 56) | HD(n = 56) | ||
Age (years) | 79.51 ± 3.45 (79.00 [77.00, 82.00]) | 79.95 ± 4.61 (78.00 [76.00, 83.00]) | 0.431 | 79.46 ± 3.26 (79.00 [77.00, 82.00]) | 80.30 ± 4.34 (79.00 [77.00, 84.00]) | 0.250 |
Gender, n (%) | 0.301 | 0.445 | ||||
Female | 57 (56.44) | 66 (49.62) | 30 (53.57) | 34 (60.71) | ||
Male | 44 (43.56) | 67 (50.38) | 26 (46.43) | 22 (39.29) | ||
Hemoglobin (g/L) | 81.75 ± 17.79 (80.00 [69.00, 92.50]) | 86.72 ± 21.14 (86.00 [71.00, 99.50]) | 0.059 | 85.62 ± 18.58 (82.50 [74.00, 96.25]) | 87.41 ± 21.26 (88.50 [71.75, 105.25]) | 0.637 |
Albumin (g/L) | 32.95 ± 5.39 (32.70 [28.98, 37.15]) | 33.59 ± 6.73 (34.40 [28.89, 37.75]) | 0.449 | 33.22 ± 5.53 (33.10 [28.87, 37.42]) | 33.18 ± 6.61 (33.95 [28.15, 37.53]) | 0.968 |
eGFR (ml/min/1.73 m2) | 6.56 ± 5.11 (5.26 [3.75, 7.77]) | 9.14 ± 9.54 (6.00 [4.40, 10.19]) | 0.010 | 7.52 ± 6.13 (5.94 [4.49, 8.33]) | 8.93 ± 10.51 (5.85 [4.30, 9.43]) | 0.387 |
Hypertension, n (%) | 93 (92.08) | 105 (78.95) | 0.006 | 49 (87.50) | 48 (85.71) | 0.781 |
Diabetes, n (%) | 38 (37.62) | 53 (39.85) | 0.729 | 21 (37.50) | 23 (41.07) | 0.699 |
Heart failure, n (%) | 52 (51.49) | 25 (21.19) | < 0.0.001 | 19 (33.93) | 18 (32.14) | 0.841 |
Cerebrovascular disease, n (%) | 24 (23.76) | 42 (35.59) | 0.057 | 16 (28.57) | 16 (28.57) | 1.000 |
cancer, n (%) | 4 (3.96) | 19 (16.10) | 0.003 | 4 (7.14) | 6 (10.71) | 0.508 |
Chronic pulmonary disease, n (%) | 10 (9.90) | 11 (9.32) | 0.885 | 7 (12.50) | 4 (7.14) | 0.341 |
Chronic liver disease, n (%) | 11 (10.89) | 2 (1.69) | 0.004 | 1 (1.79) | 2 (3.57) | 1.000 |
